Pharmaceutical formulation
AssigneeSmithKline Beecham Corporation
InventorDANIEL JOSEPH BURCH
Life of this patent
Estimating the term…
Abstract
Pharmaceutical formulations comprising amoxycillin and clavulanate in a ratio of from 10:1 to 20:1 are of use in the emperic treatement of infections potentially caused by DRSP.
Claims15
A pharmaceutical formulation comprising amoxycillin and clavulanate in a weight ratio between 10:1 and 20:1 inclusive.
A process for preparing a pharmaceutical formulation according to any one of the preceding claims which process comprises admixing the ingredients thereof in any order that is convenient
The use of amoxycillin and clavulanate in a ratio of between 10:1 and 20:1 inclusive in the manufacture of a medicament for oral administration for the empiric treatment of infections potentially caused by DRSP in human patients.
A method for the empiric treatment of infections potentially caused by DRSP in a human patient comprising the oral administration to a patient in need thereof of a pharmaceutical formulation comprising amoxycillin and clavulanate in a weight ratio between 10:1 and 20:1 inclusive.
Dependencies are inferred from the claim text.